His scientific interests lie mostly in Immunology, Inflammation, Internal medicine, Alcoholic liver disease and Proinflammatory cytokine. His work in Tumor necrosis factor alpha, Immune system, TLR4, Lipopolysaccharide and Innate immune system is related to Immunology. He combines subjects such as Cancer research, Toll-like receptor, Pathogenesis, Cirrhosis and Liver disease with his study of Inflammation.
He has researched Internal medicine in several fields, including Gastroenterology, Endocrinology and Ribavirin. The Alcoholic liver disease study combines topics in areas such as Liver injury and Kupffer cell. His work deals with themes such as Chemokine, TLR2 and Inflammasome, which intersect with Proinflammatory cytokine.
Gyongyi Szabo mostly deals with Immunology, Internal medicine, Alcoholic liver disease, Inflammation and Immune system. His study in Innate immune system, Tumor necrosis factor alpha, Monocyte, Cytokine and Proinflammatory cytokine falls under the purview of Immunology. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Endocrinology and Alcohol.
The study incorporates disciplines such as Liver disease, Liver injury and Steatosis in addition to Alcoholic liver disease. His Inflammation research focuses on Inflammasome in particular. His research integrates issues of Hepatitis C, Virology and Hepatitis C virus in his study of Immune system.
Internal medicine, Alcoholic liver disease, Liver disease, Alcoholic hepatitis and Inflammation are his primary areas of study. His studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology and Alcohol. His Alcoholic liver disease research includes themes of Cancer research, Steatosis, Liver injury, Immunology and Intensive care medicine.
His Immunology research is multidisciplinary, incorporating perspectives in Microvesicles and Regeneration. His study on Liver disease also encompasses disciplines like
Gyongyi Szabo spends much of his time researching Alcoholic liver disease, Internal medicine, Liver disease, Steatosis and Endocrinology. His work carried out in the field of Alcoholic liver disease brings together such families of science as Cancer research, Hepatocyte and Pathology. Gyongyi Szabo has included themes like Proinflammatory cytokine, Farnesoid X receptor, G protein-coupled bile acid receptor and Fatty liver in his Steatosis study.
His Endocrinology study integrates concerns from other disciplines, such as Inflammation, Alcoholic steatohepatitis and Gene knockdown. His TLR4 study in the realm of Inflammation connects with subjects such as Suppressor of cytokine signaling 1. His studies deal with areas such as Immunology and Sepsis as well as Alcoholic hepatitis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu;Vlad Ratziu;Stephen A. Harrison;Sven Francque;Pierre Bedossa.
Gastroenterology (2016)
Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.
Timea Csak;Michal Ganz;Justin Pespisa;Karen Kodys.
Hepatology (2011)
Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced and inflammatory liver diseases
Shashi Bala;Jan Petrasek;Shiv Mundkur;Donna Catalano.
Hepatology (2012)
Gut-liver axis in alcoholic liver disease.
Gyongyi Szabo.
Gastroenterology (2015)
Consequences of alcohol consumption on host defence
Gyongyi Szabo.
Alcohol and Alcoholism (1999)
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
Jan Petrasek;Shashi Bala;Timea Csak;Dora Lippai.
Journal of Clinical Investigation (2012)
MicroRNAs in liver disease
Gyongyi Szabo;Shashi Bala.
Nature Reviews Gastroenterology & Hepatology (2013)
Signalling pathways in alcohol-induced liver inflammation☆
Pranoti Mandrekar;Gyongyi Szabo.
Journal of Hepatology (2009)
Inflammasomes in liver diseases
Gyongyi Szabo;Timea Csak.
Journal of Hepatology (2012)
Inflammasome activation and function in liver disease
Gyongyi Szabo;Jan Petrasek.
Nature Reviews Gastroenterology & Hepatology (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Massachusetts Medical School
University of Massachusetts Medical School
University of Louisville
University of Massachusetts Medical School
California State University, Long Beach
Brigham and Women's Hospital
Harvard University
Saint Louis University
University of Massachusetts Medical School
National Institutes of Health
University of Illinois at Urbana-Champaign
Indian Institute of Technology Kharagpur
Tokyo University of Science
Ionis Pharmaceuticals (United States)
University of Mississippi
University of Sydney
University of Erlangen-Nuremberg
MRC Laboratory of Molecular Biology
University of Würzburg
University of California, Davis
The Ohio State University
California Institute of Technology
University of South Australia
University of Edinburgh
University of Glasgow
Leiden University